300535.Sz
The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
Business. The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
The company maintains a relatively strong liquidity position, with a current ratio of 1.46, indicating that it has sufficient short-term assets to cover its short-term liabilities. However, the free cash flow is negative at -16.8 million CNY, suggesting that the company is spending more on capital expenditures than it is generating in operating cash flow. The debt-to-equity ratio of 0.29 indicates a conservative capital structure, with total liabilities accounting for a small portion of total equity.
Profitability metrics show a return on equity of 3.74% and a return on assets of 2.46%, both of which are below the typical thresholds for high-performing companies in the Commodity Chemicals industry. The operating margin, calculated as operating income divided by revenue, is 5.87%, which is in line with the industry median of 5.9%. However, the net profit margin of 5.02% is slightly below the industry median of 5.2%, indicating that the company may be facing margin compression due to competitive pressures or cost inefficiencies.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic downturns or regulatory changes that could impact the company's primary market. The absence of segment or geographic breakdown in the financial data limits the ability to assess the company's exposure to different markets or product lines.
The company's growth trajectory is modest, with no disclosed revenue growth in the most recent fiscal year. The capital expenditure of -89.5 million CNY indicates a significant investment in long-term assets, which could support future growth but may also strain short-term liquidity. The company's operating cash flow of 70.8 million CNY provides some cushion against near-term liquidity pressures, but the negative free cash flow suggests that the company is not currently generating enough cash to sustain operations without external financing.
The company faces moderate liquidity risk, as indicated by the risk assessment, with a key flag noting that net cash is negative after subtracting total debt. The dilution risk is low, with no significant dilution expected in the near term. The company's capital structure remains stable, with a low debt-to-equity ratio and no recent signs of aggressive share issuance or dilution. The risk assessment also highlights the importance of monitoring the company's cash flow generation and capital expenditure trends to assess its long-term financial health.
Recent events include the disclosure of the company's latest financial results, which show a net income of 35.8 million CNY and an EPS of 0.38 CNY. The company has not disclosed any material changes in its business operations or strategic direction in the most recent filings. The absence of recent earnings calls or investor presentations limits the visibility into the company's near-term plans and performance expectations.
- The company has a conservative capital structure with a low debt-to-equity ratio of 0.29.
- Profitability metrics are in line with industry medians, but the net profit margin is slightly below the industry average.
- The company's revenue is concentrated in a single business segment, increasing exposure to regional and market-specific risks.
- Free cash flow is negative, indicating that the company is spending more on capital expenditures than it is generating in operating cash flow.
- The company faces moderate liquidity risk, with a current ratio of 1.46 and a negative net cash position after subtracting total debt.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 300535.SZ Market data — financials · 2026-05-26
- Sichuan Dowell Science and Technology Inc Market data — analyst estimates · 2026-05-26